B&M's 'perfect' £4 fitness hack that shoppers can't wait to try
Well, to make those goals a little bit easier to reach, B&M have launched the perfect 2025 fitness hack and there is no need ...
GlobalData on MSN12h
FDA beats EMA to most approved new drugs in 2024
The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in ...
What is Leerink Partnrs’ Estimate for BMY Q4 Earnings?
Analysts at Leerink Partnrs boosted their Q4 2024 EPS estimates for Bristol-Myers Squibb in a report released on Sunday, ...
bovnews11h
Bristol-Myers Squibb Co (BMY) Stock Posted a Gross Margin of 55.87% Over the Past Year: Is This Justifiable?
Jefferies has recently raised Bristol-Myers Squibb Co (BMY) stock to Buy rating, as announced on December 16, 2024, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the ...
Zacks.com on MSN1h
Bristol Myers Squibb (BMY) Stock Dips While Market Gains: Key Facts
Bristol Myers Squibb (BMY) ended the recent trading session at $56.29, demonstrating a -0.16% swing from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain ...
Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
Welcome to “Sector Spotlight,” where The Fly looks at a new industry every week and highlights its happenings. Stay Ahead of the ...